PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsNATCO Pharma
NATCO Pharma
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations active pharmaceutical ingredients and crop health science products, and also provides contract manufacturing services. It is a major producer of branded oncology medicines and hepatitis C drugs. The company specialises in producing complex medicines at affordable prices. In 2019, Natco launched its crop health sciences division.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
AlprazolamAlprazolam2015-04-15
Panic disorder
,
Depressive disorder
,
Agoraphobia
AnastrozoleAnastrozole2010-06-28
Breast neoplasms
ArmodafinilArmodafinil2016-11-28
Sleep wake disorders
AzacitidineAzacitidine2017-06-232029-2030
Myelodysplastic syndromes,
Myeloid leukemia acute,
Myelomonocytic leukemia chronic,
Sideroblastic anemia,
Refractory anemia
BosentanBosentan2019-04-262026-2027
Pulmonary hypertension,
Systemic scleroderma
BudesonideBudesonide2016-11-232026-2043
Chronic obstructive pulmonary disease,
Asthma,
Inflammatory bowel diseases,
Allergic rhinitis perennial,
Bronchial spasm,
Hyperhidrosis,
Iga glomerulonephritis,
Esophageal diseases,
Respiratory tract diseases,
Peptic ulcer,
Drug-induced abnormalities
CarisoprodolCarisoprodol2014-10-28
Myositis,
Pain,
Muscle spasticity,
Muscle cramp,
Spasm,
Muscle rigidity,
Rheumatoid arthritis,
Fever,
Inflammation,
Osteoarthritis,
Rheumatic fever,
Gout,
Cough
ChloroquineChloroquine2011-01-21
Malaria,
Systemic scleroderma,
Rheumatoid arthritis,
Discoid lupus erythematosus,
Falciparum malaria,
Pemphigus,
Amebiasis,
Avian malaria,
Vivax malaria
CitalopramCitalopram2008-04-10
Alcoholism,
Tobacco use disorder,
Diabetic neuropathies,
Dementia,
Obsessive-compulsive disorder,
Depressive disorder
ErlotinibErlotinib2019-11-05
Pancreatic neoplasms,
Non-small-cell lung carcinoma
GlycopyrrolateGlycopyrrolate2016-06-202024-2038
Respiratory tract diseases,
Peptic ulcer,
Drug-induced abnormalities,
Asthma,
Bronchial spasm,
Inflammatory bowel diseases,
Allergic rhinitis perennial,
Chronic bronchitis,
Pulmonary emphysema,
Urinary retention,
Myasthenia gravis,
Urinary bladder diseases
GranisetronGranisetron2009-06-222024-2025
Neoplasms,
Vomiting
ImatinibImatinib2019-03-01
Precursor cell lymphoblastic leukemia-lymphoma,
Bcr-abl positive chronic myelogenous leukemia,
Myelodysplastic-myeloproliferative diseases,
Systemic mastocytosis,
Myeloid leukemia,
Hypereosinophilic syndrome,
Lymphoid leukemia,
Dermatofibrosarcoma,
Gastrointestinal stromal tumors
1
2
3
4
5
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Taxane
ovarian neoplasms
,
fallopian tube neoplasms
,
ovarian epithelial carcinoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use